Literature DB >> 849811

Glucagon secretion induced by natural and artificial amino acids in the perfused rat pancreas.

R Assan, J R Attali, G Ballerio, J Boillot, J R Girard.   

Abstract

The glucagon-secreting potency of 22 amino acids was investigated in the rat isolated perfused pancreas. Arginine and the structurally related amino acids were the most potent A2-cell stimulators that induced a biphasic and sustained glucagon release. Dose-response curver were different for L(+) and D(+)arginine, and the suppressor effect of glucose on the response to L(+) arginine was not detected in the presence of D(+) arginine or homoarginine. Citrulline was the only exception among the arginine-related amino acids; it displayed neither stimulatory nor inhibitory potency on glucagon release. The A2-cell response to D(+) amino acids and artificial analogues of arginine is a strong case for the theory of amino acid receptors' triggering the release of the hormone before (or in the absence of) further metabolism. The prominent rank of arginine and ornithine amont stimulatory amino acids and some other physiologic evidence suggest that A2-cell may play a regulatory role in the metabolsm of ammonia by the liver.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849811     DOI: 10.2337/diab.26.4.300

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Physiological concentrations of oxytocin powerfully stimulate insulin secretionin vitro.

Authors:  E Bobbioni-Harsch; S Frütiger; G Hughes; M Panico; A Etienne; F Zappacosta; H R Morris; B Jeanrenaud
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

2.  Possible involvement of the cholinergic system in hormonal secretion by the perfused pancreas from ventromedial-hypothalamic lesioned rats.

Authors:  F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

3.  Effect of oleic acid on arginine-induced glucagon secretion by the isolated perfused rat pancreas.

Authors:  J E Campillo; A S Luyckx; P J Lefebvre
Journal:  Acta Diabetol Lat       Date:  1979 Oct-Dec

4.  Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patients.

Authors:  V Gasco; G Beccuti; F Marotta; N Prencipe; M Maccario; J Janssen; A J van der Lely; E Ghigo; S Grottoli
Journal:  J Endocrinol Invest       Date:  2011-05-31       Impact factor: 4.256

5.  Ambiguous effects of colchicine and vincristine upon A2-cell response to arginine.

Authors:  R Assan; E Soufflet; G Ballerio; J R Attaili; J Boillot; J R Girard
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

6.  Consequences of ventromedial hypothalamic lesions upon insulin and glucagon secretion by subsequently isolated perfused pancreases in the rat.

Authors:  F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

7.  Interactions of alpha-ketoisocaproate, glucose and arginine in the secretion of glucagon and insulin from the perfused rat pancreas.

Authors:  V Leclercq-Meyer; J Marchand; R Leclercq; W J Malaisse
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

8.  A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids.

Authors:  S Charles; T Tamagawa; J C Henquin
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

9.  Oversecretion of glucagon by pancreases of ventromedial hypothalamic-lesioned rats: a re-evaluation of a controversial topic.

Authors:  F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

10.  Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.

Authors:  Katrine D Galsgaard; Marie Winther-Sørensen; Cathrine Ørskov; Hannelouise Kissow; Steen S Poulsen; Hendrik Vilstrup; Cornelia Prehn; Jerzy Adamski; Sara L Jepsen; Bolette Hartmann; Jenna Hunt; Maureen J Charron; Jens Pedersen; Nicolai J Wewer Albrechtsen; Jens J Holst
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.